China Hospital Development and Investment Report, 2014-2017

September 1, 2014

DUBLIN, Sept. 1, 2014 /PRNewswire/ – Research and Markets has announced the addition of the “China Hospital Development and Investment Report, 2014-2017″ report to their offering.


China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6% in 2011-2013, higher than 2.26% in 2005-2010. The revenue of China hospital industry jumped at a CAGR of 23.6% in 2011-2013, and it is expected to maintain the growth rate of over 20% and hit RMB4.07 trillion in 2017.

At the same time, various social capital flows to the Chinese hospital market by self-establishment, mergers and acquisitions (including participation in the restructuring of public hospitals), joint ventures, associates and other forms, which boosts the expansion of private hospitals. As of the end of 2013, Chinese private hospitals had accounted for 45.8% of the total Chinese hospitals, increasing by 24.5 percentage points compared with 2006. However, from the point of view of revenue structure, public hospitals still took a dominant position with the proportion of over 90%, but the figure shows a decreasing trend now.

Key Topics Covered:

1. Overview of China Hospital Industry

2. Overview of China Hospital Market

3. Current Development of Specialized Hospitals in China

4. Development Forecast of China Hospital Industry

5. Investment in China Hospital Industry

6 Major Chinese Enterprises

7 Summary and Forecast

Companies Mentioned:

    --  Aier Eye Hospital Group
    --  CMS Holdings Ltd.
    --  China Resources Sanjiu
    --  Inner Mongolia Furui Medical Science
    --  Jiangnan Mould & Plastic Technology
    --  Jinling Pharmaceutical
    --  Kangmei Pharmaceutical
    --  Mayinglong Pharm
    --  Parkway Pantai
    --  Phoenix Healthcare
    --  Shanghai Fosun Pharmaceutical
    --  Shinva Medical
    --  TC Medical
    --  United Family Hospital
    --  Wuhan Jianmin Pharmaceutical
    --  Xi'an Kaiyuan Investment
    --  Yibai Pharmaceutical

For more information visit http://www.researchandmarkets.com/research/mb5f4q/china_hospital

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

Source: PR Newswire

comments powered by Disqus